Clinical Trials Directory

Trials / Completed

CompletedNCT01316978

A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference Treatments

A Single-Dose, Randomised, Crossover Bioequivalence Study to Compare the Rate and Extent of Absorption of a Test Formulation of Ibuprofen Fast Melt Orodispersible Tablet Versus Two Reference Formulations in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
McNeil AB · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study is designed to assess bioequivalence between one test and two reference formulations used for treatment of headaches and temporary relief of pain.

Detailed description

The study is a single dose, randomized, three-way crossover study in 30 healthy subjects, with equal numbers of males and females (minimum of 13 of either gender). Drop-outs will not be replaced. The three doses of medication given in the study (a single dose in each of the three study periods) will each be separated by a washout period of at least 7 calendar days. In each study period, eighteen (18) blood samples for pharmacokinetic analysis will be taken over 12 hours. Blood samples will be centrifuged and concentrations of ibuprofen (R-enantiomer and S-enantiomer) in plasma will be measured using a validated chromatographic assay. Pharmacokinetic parameters will be calculated from plasma concentration data \[R-enantiomer, S-enantiomer and total (sum of both enantiomers)\]. The rate and extent of absorption of the formulations will be compared.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofenA single 2 x 100 mg dose of an experimental Ibuprofen Fast Melt Orodispersible Tablet administered orally, with a 7-day washout between visits
DRUGIbuprofenA single 200 mg Nurofen Meltlets Orodispersible Tablet administered orally, with a 7-day washout between visits
DRUGIbuprofenA single 2 x 100 mg dose of Junior Strength Motrin Chewable Tablet administered orally, with a 7-day washout between visits

Timeline

Start date
2011-02-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2011-03-16
Last updated
2012-07-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01316978. Inclusion in this directory is not an endorsement.